357 related articles for article (PubMed ID: 20805359)
1. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase inhibitors and basement membrane interact to regulate breast epithelial cell differentiation and acinar morphogenesis.
Coppock HA; Gilham DE; Howell A; Clarke RB
Cell Prolif; 2007 Oct; 40(5):721-40. PubMed ID: 17877612
[TBL] [Abstract][Full Text] [Related]
3. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
4. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord.
Gui H; Li S; Matise MP
Dev Biol; 2007 Jan; 301(1):14-26. PubMed ID: 17123502
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
Kim DK; Lee JH; Lee OJ; Park CH
J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
7. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors.
Cerqueira A; MartÃn A; Symonds CE; Odajima J; Dubus P; Barbacid M; SantamarÃa D
Mol Cell Biol; 2014 Apr; 34(8):1452-9. PubMed ID: 24515438
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
11. Development of mice without Cip/Kip CDK inhibitors.
Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
[TBL] [Abstract][Full Text] [Related]
12. The influence of high glucose on the Cip/Kip family expression profiles in HRECs.
Tian J; Ma H; Luo Y; Hu A; Lin S; Li T; Guo K; Li J; Cai M; Tang S
J Mol Histol; 2013 Dec; 44(6):705-13. PubMed ID: 23636608
[TBL] [Abstract][Full Text] [Related]
13. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.
Kim YK; Yu J; Han TS; Park SY; Namkoong B; Kim DH; Hur K; Yoo MW; Lee HJ; Yang HK; Kim VN
Nucleic Acids Res; 2009 Apr; 37(5):1672-81. PubMed ID: 19153141
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
[TBL] [Abstract][Full Text] [Related]
15. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.
Bryant P; Zheng Q; Pumiglia K
Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171
[TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
18. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
19. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
20. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
Clark ES; Brown B; Whigham AS; Kochaishvili A; Yarbrough WG; Weaver AM
Oncogene; 2009 Jan; 28(3):431-44. PubMed ID: 18931703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
